カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の組換えアルブミン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Recombinant Albumin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19595）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19595
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：99
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の組換えアルブミン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

組換えアルブミン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の組換えアルブミンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

組換えアルブミン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・OsrHSA、ScrHSA

用途別セグメントは次のように区分されます。
・細胞培養液、医薬品、その他

世界の組換えアルブミン市場の主要な市場プレーヤーは以下のとおりです。
・Albumedix、Merck、Ventria (InVitria)、NCPC、Oryzogen、HiMedia

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、組換えアルブミン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な組換えアルブミンメーカーの企業概要、2019年～2022年までの組換えアルブミンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な組換えアルブミンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別組換えアルブミンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの組換えアルブミンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での組換えアルブミン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および組換えアルブミンの産業チェーンを掲載しています。
・第13、14、15章では、組換えアルブミンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 組換えアルブミンの概要
- 種類別分析（2017年vs2021年vs2028年）：OsrHSA、ScrHSA
- 用途別分析（2017年vs2021年vs2028年）：細胞培養液、医薬品、その他
- 世界の組換えアルブミン市場規模・予測
- 世界の組換えアルブミン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Albumedix、Merck、Ventria (InVitria)、NCPC、Oryzogen、HiMedia
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：OsrHSA、ScrHSA
・用途別分析2017年-2028年：細胞培養液、医薬品、その他
・組換えアルブミンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・組換えアルブミンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・組換えアルブミンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・組換えアルブミンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・組換えアルブミンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Recombinant Albumin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Recombinant Albumin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Cell Culture Media accounting for % of the Recombinant Albumin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While OsrHSA segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Recombinant Albumin include Albumedix, Merck, Ventria (InVitria), NCPC, and Oryzogen, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Recombinant Albumin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
OsrHSA
ScrHSA
Market segment by Application can be divided into
Cell Culture Media
Medical Supplements
Other
The key market players for global Recombinant Albumin market are listed below:
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Albumin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Albumin, with price, sales, revenue and global market share of Recombinant Albumin from 2019 to 2022.
Chapter 3, the Recombinant Albumin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Albumin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Recombinant Albumin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Recombinant Albumin.
Chapter 13, 14, and 15, to describe Recombinant Albumin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Recombinant Albumin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Albumin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 OsrHSA
1.2.3 ScrHSA
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Albumin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.3.4 Other
1.4 Global Recombinant Albumin Market Size & Forecast
1.4.1 Global Recombinant Albumin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Recombinant Albumin Sales in Volume (2017-2028)
1.4.3 Global Recombinant Albumin Price (2017-2028)
1.5 Global Recombinant Albumin Production Capacity Analysis
1.5.1 Global Recombinant Albumin Total Production Capacity (2017-2028)
1.5.2 Global Recombinant Albumin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Albumin Market Drivers
1.6.2 Recombinant Albumin Market Restraints
1.6.3 Recombinant Albumin Trends Analysis
2 Manufacturers Profiles
2.1 Albumedix
2.1.1 Albumedix Details
2.1.2 Albumedix Major Business
2.1.3 Albumedix Recombinant Albumin Product and Services
2.1.4 Albumedix Recombinant Albumin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Recombinant Albumin Product and Services
2.2.4 Merck Recombinant Albumin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Ventria (InVitria)
2.3.1 Ventria (InVitria) Details
2.3.2 Ventria (InVitria) Major Business
2.3.3 Ventria (InVitria) Recombinant Albumin Product and Services
2.3.4 Ventria (InVitria) Recombinant Albumin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 NCPC
2.4.1 NCPC Details
2.4.2 NCPC Major Business
2.4.3 NCPC Recombinant Albumin Product and Services
2.4.4 NCPC Recombinant Albumin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Oryzogen
2.5.1 Oryzogen Details
2.5.2 Oryzogen Major Business
2.5.3 Oryzogen Recombinant Albumin Product and Services
2.5.4 Oryzogen Recombinant Albumin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 HiMedia
2.6.1 HiMedia Details
2.6.2 HiMedia Major Business
2.6.3 HiMedia Recombinant Albumin Product and Services
2.6.4 HiMedia Recombinant Albumin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Recombinant Albumin Breakdown Data by Manufacturer
3.1 Global Recombinant Albumin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Recombinant Albumin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Recombinant Albumin
3.4 Market Concentration Rate
3.4.1 Top 3 Recombinant Albumin Manufacturer Market Share in 2021
3.4.2 Top 6 Recombinant Albumin Manufacturer Market Share in 2021
3.5 Global Recombinant Albumin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Recombinant Albumin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Recombinant Albumin Market Size by Region
4.1.1 Global Recombinant Albumin Sales in Volume by Region (2017-2028)
4.1.2 Global Recombinant Albumin Revenue by Region (2017-2028)
4.2 North America Recombinant Albumin Revenue (2017-2028)
4.3 Europe Recombinant Albumin Revenue (2017-2028)
4.4 Asia-Pacific Recombinant Albumin Revenue (2017-2028)
4.5 South America Recombinant Albumin Revenue (2017-2028)
4.6 Middle East and Africa Recombinant Albumin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Recombinant Albumin Sales in Volume by Type (2017-2028)
5.2 Global Recombinant Albumin Revenue by Type (2017-2028)
5.3 Global Recombinant Albumin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Recombinant Albumin Sales in Volume by Application (2017-2028)
6.2 Global Recombinant Albumin Revenue by Application (2017-2028)
6.3 Global Recombinant Albumin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Recombinant Albumin Sales by Type (2017-2028)
7.2 North America Recombinant Albumin Sales by Application (2017-2028)
7.3 North America Recombinant Albumin Market Size by Country
7.3.1 North America Recombinant Albumin Sales in Volume by Country (2017-2028)
7.3.2 North America Recombinant Albumin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Recombinant Albumin Sales by Type (2017-2028)
8.2 Europe Recombinant Albumin Sales by Application (2017-2028)
8.3 Europe Recombinant Albumin Market Size by Country
8.3.1 Europe Recombinant Albumin Sales in Volume by Country (2017-2028)
8.3.2 Europe Recombinant Albumin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Recombinant Albumin Sales by Type (2017-2028)
9.2 Asia-Pacific Recombinant Albumin Sales by Application (2017-2028)
9.3 Asia-Pacific Recombinant Albumin Market Size by Region
9.3.1 Asia-Pacific Recombinant Albumin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Recombinant Albumin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Recombinant Albumin Sales by Type (2017-2028)
10.2 South America Recombinant Albumin Sales by Application (2017-2028)
10.3 South America Recombinant Albumin Market Size by Country
10.3.1 South America Recombinant Albumin Sales in Volume by Country (2017-2028)
10.3.2 South America Recombinant Albumin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Recombinant Albumin Sales by Type (2017-2028)
11.2 Middle East & Africa Recombinant Albumin Sales by Application (2017-2028)
11.3 Middle East & Africa Recombinant Albumin Market Size by Country
11.3.1 Middle East & Africa Recombinant Albumin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Recombinant Albumin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Recombinant Albumin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Recombinant Albumin
12.3 Recombinant Albumin Production Process
12.4 Recombinant Albumin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Recombinant Albumin Typical Distributors
13.3 Recombinant Albumin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Recombinant Albumin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Recombinant Albumin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Albumedix Basic Information, Manufacturing Base and Competitors
Table 4. Albumedix Major Business
Table 5. Albumedix Recombinant Albumin Product and Services
Table 6. Albumedix Recombinant Albumin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Recombinant Albumin Product and Services
Table 10. Merck Recombinant Albumin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Ventria (InVitria) Basic Information, Manufacturing Base and Competitors
Table 12. Ventria (InVitria) Major Business
Table 13. Ventria (InVitria) Recombinant Albumin Product and Services
Table 14. Ventria (InVitria) Recombinant Albumin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. NCPC Basic Information, Manufacturing Base and Competitors
Table 16. NCPC Major Business
Table 17. NCPC Recombinant Albumin Product and Services
Table 18. NCPC Recombinant Albumin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Oryzogen Basic Information, Manufacturing Base and Competitors
Table 20. Oryzogen Major Business
Table 21. Oryzogen Recombinant Albumin Product and Services
Table 22. Oryzogen Recombinant Albumin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. HiMedia Basic Information, Manufacturing Base and Competitors
Table 24. HiMedia Major Business
Table 25. HiMedia Recombinant Albumin Product and Services
Table 26. HiMedia Recombinant Albumin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Recombinant Albumin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Recombinant Albumin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Recombinant Albumin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Recombinant Albumin Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Recombinant Albumin Production Site of Key Manufacturer
Table 32. Recombinant Albumin New Entrant and Capacity Expansion Plans
Table 33. Recombinant Albumin Mergers & Acquisitions in the Past Five Years
Table 34. Global Recombinant Albumin Sales by Region (2017-2022) & (K Units)
Table 35. Global Recombinant Albumin Sales by Region (2023-2028) & (K Units)
Table 36. Global Recombinant Albumin Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Recombinant Albumin Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Recombinant Albumin Sales by Type (2017-2022) & (K Units)
Table 39. Global Recombinant Albumin Sales by Type (2023-2028) & (K Units)
Table 40. Global Recombinant Albumin Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Recombinant Albumin Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Recombinant Albumin Price by Type (2017-2022) & (US$/Unit)
Table 43. Global Recombinant Albumin Price by Type (2023-2028) & (US$/Unit)
Table 44. Global Recombinant Albumin Sales by Application (2017-2022) & (K Units)
Table 45. Global Recombinant Albumin Sales by Application (2023-2028) & (K Units)
Table 46. Global Recombinant Albumin Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Recombinant Albumin Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Recombinant Albumin Price by Application (2017-2022) & (US$/Unit)
Table 49. Global Recombinant Albumin Price by Application (2023-2028) & (US$/Unit)
Table 50. North America Recombinant Albumin Sales by Country (2017-2022) & (K Units)
Table 51. North America Recombinant Albumin Sales by Country (2023-2028) & (K Units)
Table 52. North America Recombinant Albumin Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Recombinant Albumin Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Recombinant Albumin Sales by Type (2017-2022) & (K Units)
Table 55. North America Recombinant Albumin Sales by Type (2023-2028) & (K Units)
Table 56. North America Recombinant Albumin Sales by Application (2017-2022) & (K Units)
Table 57. North America Recombinant Albumin Sales by Application (2023-2028) & (K Units)
Table 58. Europe Recombinant Albumin Sales by Country (2017-2022) & (K Units)
Table 59. Europe Recombinant Albumin Sales by Country (2023-2028) & (K Units)
Table 60. Europe Recombinant Albumin Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Recombinant Albumin Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Recombinant Albumin Sales by Type (2017-2022) & (K Units)
Table 63. Europe Recombinant Albumin Sales by Type (2023-2028) & (K Units)
Table 64. Europe Recombinant Albumin Sales by Application (2017-2022) & (K Units)
Table 65. Europe Recombinant Albumin Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Recombinant Albumin Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Recombinant Albumin Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Recombinant Albumin Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Recombinant Albumin Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Recombinant Albumin Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Recombinant Albumin Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Recombinant Albumin Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Recombinant Albumin Sales by Application (2023-2028) & (K Units)
Table 74. South America Recombinant Albumin Sales by Country (2017-2022) & (K Units)
Table 75. South America Recombinant Albumin Sales by Country (2023-2028) & (K Units)
Table 76. South America Recombinant Albumin Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Recombinant Albumin Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Recombinant Albumin Sales by Type (2017-2022) & (K Units)
Table 79. South America Recombinant Albumin Sales by Type (2023-2028) & (K Units)
Table 80. South America Recombinant Albumin Sales by Application (2017-2022) & (K Units)
Table 81. South America Recombinant Albumin Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Recombinant Albumin Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Recombinant Albumin Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Recombinant Albumin Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Recombinant Albumin Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Recombinant Albumin Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Recombinant Albumin Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Recombinant Albumin Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Recombinant Albumin Sales by Application (2023-2028) & (K Units)
Table 90. Recombinant Albumin Raw Material
Table 91. Key Manufacturers of Recombinant Albumin Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Recombinant Albumin Typical Distributors
Table 95. Recombinant Albumin Typical Customers
List of Figures
Figure 1. Recombinant Albumin Picture
Figure 2. Global Recombinant Albumin Revenue Market Share by Type in 2021
Figure 3. OsrHSA
Figure 4. ScrHSA
Figure 5. Global Recombinant Albumin Revenue Market Share by Application in 2021
Figure 6. Cell Culture Media
Figure 7. Medical Supplements
Figure 8. Other
Figure 9. Global Recombinant Albumin Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Recombinant Albumin Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Recombinant Albumin Sales (2017-2028) & (K Units)
Figure 12. Global Recombinant Albumin Price (2017-2028) & (US$/Unit)
Figure 13. Global Recombinant Albumin Production Capacity (2017-2028) & (K Units)
Figure 14. Global Recombinant Albumin Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Recombinant Albumin Market Drivers
Figure 16. Recombinant Albumin Market Restraints
Figure 17. Recombinant Albumin Market Trends
Figure 18. Global Recombinant Albumin Sales Market Share by Manufacturer in 2021
Figure 19. Global Recombinant Albumin Revenue Market Share by Manufacturer in 2021
Figure 20. Recombinant Albumin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Recombinant Albumin Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Recombinant Albumin Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Recombinant Albumin Sales Market Share by Region (2017-2028)
Figure 24. Global Recombinant Albumin Revenue Market Share by Region (2017-2028)
Figure 25. North America Recombinant Albumin Revenue (2017-2028) & (USD Million)
Figure 26. Europe Recombinant Albumin Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Recombinant Albumin Revenue (2017-2028) & (USD Million)
Figure 28. South America Recombinant Albumin Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Recombinant Albumin Revenue (2017-2028) & (USD Million)
Figure 30. Global Recombinant Albumin Sales Market Share by Type (2017-2028)
Figure 31. Global Recombinant Albumin Revenue Market Share by Type (2017-2028)
Figure 32. Global Recombinant Albumin Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Recombinant Albumin Sales Market Share by Application (2017-2028)
Figure 34. Global Recombinant Albumin Revenue Market Share by Application (2017-2028)
Figure 35. Global Recombinant Albumin Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Recombinant Albumin Sales Market Share by Type (2017-2028)
Figure 37. North America Recombinant Albumin Sales Market Share by Application (2017-2028)
Figure 38. North America Recombinant Albumin Sales Market Share by Country (2017-2028)
Figure 39. North America Recombinant Albumin Revenue Market Share by Country (2017-2028)
Figure 40. United States Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Recombinant Albumin Sales Market Share by Type (2017-2028)
Figure 44. Europe Recombinant Albumin Sales Market Share by Application (2017-2028)
Figure 45. Europe Recombinant Albumin Sales Market Share by Country (2017-2028)
Figure 46. Europe Recombinant Albumin Revenue Market Share by Country (2017-2028)
Figure 47. Germany Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Recombinant Albumin Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Recombinant Albumin Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Recombinant Albumin Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Recombinant Albumin Revenue Market Share by Region (2017-2028)
Figure 56. China Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Recombinant Albumin Sales Market Share by Type (2017-2028)
Figure 63. South America Recombinant Albumin Sales Market Share by Application (2017-2028)
Figure 64. South America Recombinant Albumin Sales Market Share by Country (2017-2028)
Figure 65. South America Recombinant Albumin Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Recombinant Albumin Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Recombinant Albumin Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Recombinant Albumin Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Recombinant Albumin Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Recombinant Albumin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Recombinant Albumin in 2021
Figure 77. Manufacturing Process Analysis of Recombinant Albumin
Figure 78. Recombinant Albumin Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のアンチトロンビン（組換え）市場2022年：市場規模予測（～2028年）
  • 世界のフォン・ヴィレブランド因子（組換え）市場2022年：市場規模予測（～2028年）
  • 世界の血中アルブミン市場2022年：市場規模予測（～2028年）
  • 組換えカスケード試薬（rCR）＆組換えファクターCのグローバル市場展望 2023年-2029年：リコンビナントファクターC、リコンビナントカスケード試薬（rCR）
  • 組換えリムルス＆組換えファクターC試薬のグローバル市場展望 2023年-2029年：組換えリムルス試薬、組換えファクターC
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19595 )"世界の組換えアルブミン市場2022年：市場規模予測（～2028年）" (英文：Global Recombinant Albumin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。